Advances in tumor diagnosis and treatment, especially the use of targeted therapies, have
remarkably improved the survival rate of patients with renal cell carcinoma (RCC) …

Background/Aim: Hypertension is a risk factor for occurrence of renal cell carcinoma;
however, it remains unclear whether hypertension affects development and prognosis of …

Cancer and cardiovascular disease (CVD) accounts for nearly 50% of all mortality in the
United States (US)[1]. It is common practice to view cardiovascular (CV) risk factors and …

Cardiovascular disease remains the primary cause of mortality globally, being responsible
for an estimated 17 million deaths every year. Cancer is the second leading cause of death …

Cancer is one of the leading causes of death worldwide. With the introduction of newer
chemotherapeutic agents, targeted therapies, and immunotherapy, the prognosis and …

Background and aims Although the importance of hypertension in patients with cancer is
widely recognized, little is known about the risk of developing hypertension in patients with a …

The survival rates of many cancers have significantly improved due to recent advancements
in cancer screening and therapeutics. Although better cancer outcomes are encouraging …

Background Hypertension is usually associated with increased cardiovascular mortality.
Uncertainty exists about the possible role of hypertension as a poor prognostic factor for …

Background Conflicting evidence exists regarding the effect of hypertension on the
prognosis of metastatic renal cell carcinoma (mRCC) patients treated with tyrosine kinase …

Background Co-morbidities may induce local and systemic tumor progression of renal cell
carcinoma (RCC); however, the prognostic impact of co-morbidities has not yet been well …